Administration of COVID-19 vaccines in immunocompromised patients.

ABSTRACT: Since the beginning of vaccination programs against COVID-19 in different countries, several populations such as patients with specific immunological conditions have been considered as the priorities for immunization. In this regard, patients with autoimmune diseases or those receiving immunosuppressive agents and anti-cancer therapies, need special attention. However, no confirmed data is presently available regarding COVID-19 vaccines in these populations due to exclusion from the conducted clinical trials. Given the probable suppression or over-activation of the immune system in such patients, reaching a consensus for their vaccination is critical, besides gathering data and conducting trials, which could probably clarify this matter in the future. In this review, besides a brief on the

SUBMITTER: Negahdaripour M 

PROVIDER: S-EPMC8316069 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature